FDA Approves Novavax COVID Vaccine After Delay, Limits Use to Smaller High-Risk Population on May 19, 2025 Approved COVID19 (disease) Elderly (population group) Health conditions:-:Point in time:^Patient:- Novavax protein-based vaccine restricted population United States Food and Drug Administration Vaccines +